These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27688145)

  • 1. Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis.
    Dahlqvist G; Gaouar F; Carrat F; Meurisse S; Chazouillères O; Poupon R; Johanet C; Corpechot C;
    Hepatology; 2017 Jan; 65(1):152-163. PubMed ID: 27688145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
    Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
    J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?
    Sun C; Xiao X; Yan L; Sheng L; Wang Q; Jiang P; Lian M; Li Y; Wei Y; Zhang J; Chen Y; Li B; Li Y; Huang B; Li Y; Peng Y; Chen X; Fang J; Qiu D; Hua J; Tang R; Leung P; Gershwin ME; Miao Q; Ma X
    J Autoimmun; 2019 May; 99():33-38. PubMed ID: 30709684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis.
    Juliusson G; Imam M; Björnsson ES; Talwalkar JA; Lindor KD
    Scand J Gastroenterol; 2016; 51(6):745-52. PubMed ID: 26776319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study.
    Muratori P; Efe C; Muratori L; Ozaslan E; Schiano T; Yoshida EM; Heurgué-Berlot A; Lalanne C; Lenzi M; Wahlin S
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):777-780. PubMed ID: 28328618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How to understand the clinical significance of autoantibodies in primary biliary cholangitis].
    Yan HP; Zhang HP; Chen XX
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):810-815. PubMed ID: 29325273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary biliary cirrhosis in antimitochondrial antibody-negative patients: Chang Gung Memorial Hospital experience.
    Tsou YK; Yeh CT
    Chang Gung Med J; 2003 May; 26(5):323-9. PubMed ID: 12934848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up.
    Gulamhusein AF; Juran BD; Atkinson EJ; McCauley B; Schlicht E; Lazaridis KN
    Liver Int; 2016 Sep; 36(9):1378-82. PubMed ID: 27062298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis.
    Lazaridis KN; Juran BD; Boe GM; Slusser JP; de Andrade M; Homburger HA; Ghosh K; Dickson ER; Lindor KD; Petersen GM
    Hepatology; 2007 Sep; 46(3):785-92. PubMed ID: 17680647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring pathogenesis of primary biliary cholangitis by proteomics: A pilot study.
    Deng CW; Wang L; Fei YY; Hu CJ; Yang YJ; Peng LY; Zeng XF; Zhang FC; Li YZ
    World J Gastroenterol; 2017 Dec; 23(48):8489-8499. PubMed ID: 29358857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis.
    Cho YJ; Han DS; Kim TY; Jang SJ; Jeon YC; Sohn JH; Lee IH; Park KN
    J Korean Med Sci; 1999 Feb; 14(1):102-6. PubMed ID: 10102534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.
    Terziroli Beretta-Piccoli B; Stirnimann G; Mertens J; Semela D; Zen Y; Mazzucchelli L; Voreck A; Kolbus N; Merlo E; Di Bartolomeo C; Messina P; Cerny A; Costantini S; Vergani D; Mieli-Vergani G;
    J Autoimmun; 2021 Jan; 116():102578. PubMed ID: 33229138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease?
    Kadokawa Y; Omagari K; Ohba K; Masuda J; Hazama H; Kinoshita H; Ohnita K; Mizuta Y; Tanioka H; Imanishi T; Kohno S
    Liver Int; 2005 Apr; 25(2):317-24. PubMed ID: 15780056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
    Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
    Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.
    Zhu YJ; Li J; Liu YG; Jiang Y; Cheng XJ; Han X; Wang CY; Li J
    World J Gastroenterol; 2023 Sep; 29(34):5075-5081. PubMed ID: 37753365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
    Zhang FK; Jia JD; Wang BE
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of primary biliary cirrhosis: a report of 42 cases].
    Dai Y; Liang YH; Xie PY; Chen BW; Liu XG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):410-4. PubMed ID: 16086064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
    Zhao DT; Liu YM; Han Y; Zhang HP; Zhao Y; Yan HP
    Medicine (Baltimore); 2020 Jan; 99(3):e18856. PubMed ID: 32011506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up.
    Zandanell S; Strasser M; Feldman A; Tevini J; Strebinger G; Niederseer D; Pohla-Gubo G; Huber-Schönauer U; Ruhaltinger S; Paulweber B; Datz C; Felder TK; Aigner E
    J Intern Med; 2020 Apr; 287(4):395-404. PubMed ID: 31802567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
    Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.